Abu Dhabi Receives AstraZeneca’s COVID-19 Antibody Drug Evusheld
- Publish date: Tuesday، 18 January 2022 Reading time: 1 min read
- Related articles
- Abu Dhabi, Qatar Unveil Travel Deals at ATM 2025
- Bella Hadid Receives Gift from Shireen Abu Akleh’s Family
- International Visitors Swarm to Qatar After the Blockade and COVID-19
Abu Dhabi has received the first global shipment of AstraZeneca’s COVID-19 long-acting antibody medication, Evusheld, after gaining emergency use authorisation from the UAE’s Ministry of Health and Prevention.
فيديو ذات صلة
This browser does not support the video element.
Evusheld, is designed to prevent severe infection and death amongst immunocompromised patients.
Read More: Worship places in Abu Dhabi
Read More: Abu Dhabi Entry Requirements Update
Read More: December Prayer Times In Abu Dhabi
The first doses of Evusheld arrived in Abu Dhabi on Monday following a collaboration of key partners including Rafed, the UAE’s Primary Group Purchasing Organisation, along with Etihad Cargo, AstraZeneca and Abu Dhabi Airports Company.
.@DoHSocial has received the first global shipment of AstraZeneca’s Evusheild (formerly AZD7442), a medication to protect immunocompromised patients against Covid-19. pic.twitter.com/RHf61XcmMU
— مكتب أبوظبي الإعلامي (@admediaoffice) December 20, 2021
The breakthrough medication will be stored at Rafed’s distribution centre to be transported to various destinations.
This article was previously published on UAE Moments.To see the original article, click here